AURKA and neuroblastoma: We hypothesized that the mechanism of combinatorial efficacy for AURKA inhibitors plus radiation or 131I-MIBG in neuroblastoma is through cell cycle arrest in G2/M, potentially allowing for open decondensed chromatin, exposing DNA to additional radiation damage and eventually leading to increased cell death by apoptosis.